Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 138 Lymphoma, Non-Hodgkin 84 Lymphoma, Large B-Cell, Diffuse 83 Small Cell Lung Carcinoma 78 Hodgkin Disease 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Leukemia 57 Burkitt Lymphoma 56 Lung Neoplasms 49 Lymphoma, Follicular 47 Lymphoma, Mantle-Cell 44 Leukemia, Myeloid, Acute 41 Lymphoma, Large-Cell, Immunoblastic 40 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 33 Carcinoma, Non-Small-Cell Lung 30 Recurrence 26 Neuroblastoma 25 Lymphoma, B-Cell, Marginal Zone 25 Central Nervous System Neoplasms 24 Ovarian Neoplasms 18 Sarcoma 17 Brain Neoplasms 17 Dendritic Cell Sarcoma, Interdigitating 16 Congenital Abnormalities 16 Lymphoma, Large-Cell, Anaplastic 15 Breast Neoplasms 15 Testicular Neoplasms 14 Neoplasms, Plasma Cell 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

Paclitaxel 56 Carboplatin 56 Bevacizumab 43 Gemcitabine 20 Taxes 19 pembrolizumab 15 Immunoglobulin G 13 Disulfides 13 Topotecan 12 olaparib 11 Cisplatin 11 niraparib 9 Cyclophosphamide 9 liposomal doxorubicin 8 Specimen Handling 7 Docetaxel 6 Biopsy 6 mirvetuximab soravtansine 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Letrozole 5 Hyperthermic Intraperitoneal Chemotherapy 5 Drug Therapy 5 Cytoreduction Surgical Procedures 5 Albumin-Bound Paclitaxel 5 rucaparib 4 pazopanib 4 oregovomab 4 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fallopian Tube Neoplasms × Etoposide × Clear all

NCT01669226 2016-12-19

AICE

Shanghai Gynecologic Oncology Group

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡